Summary As part of a series of non-clinical studies to evaluate the safety of PureSorb-Q TM 40 (Water-soluble type CoQ 10 powder, CoQ 10 content is 40 w/w%; hereinafter referred to as P40), male and female rats were treated orally by gavage with P40 once a day for 91 d, and its repeated dose toxicity was assessed. Control animals were treated with a 0.5 w/v% solution of methylcellulose, the vehicle for P40. Each test group consisted of 6 animals of each sex. No adverse effects of P40 were noted in general signs, body weight, food consumption, ophthalmological examination, urinalysis, hematological examination, blood chemical analysis, necropsy, organ weights, or histopathological examination in animals of either sex. From these results, the no observed adverse effect level of P40 was estimated at 2,000 mg/kg in both sexes of rats under the conditions of the present study, and P40 was confirmed to be a food material whose safety is high.
40, toxicity
Coenzyme Q 10 ("CoQ 10 " hereafter), a lipid-soluble substance that plays important roles in organisms as an essential factor in the mitochondrial electron transfer system, is a biofactor directly involved in the energy production system of organisms ( 1 , 2 ) . CoQ 10 , which was chemically synthesized in 1958 ( 3 ) and whose safety is high, has widely been used in many countries, including Japan, as a substance serving as a functional food material or as a raw material for producing cosmetics ( 4 -6 ). CoQ 10 is biosynthesized not only by mitochondria but also by the microsome-Golgi system, so that it does not fit the definition of a vitamin ( 7 ) . However, CoQ 10 mostly occurs not in an oxidized form but in a reduced form in the tissues of many species of animals, including humans, and has a potent antioxidant action in organisms ( 8 , 9 ) .
CoQ 10 is not easily absorbed into organisms due to its high lipid-solubility. Even when it is taken with food, the absorption rate is about 3% ( 10 ) . The use of CoQ 10 in food products is also limited because of its high lipid-solubility. PureSorb-Q TM 40 (Water-soluble type CoQ 10 powder, CoQ 10 content is 40 w/w%; hereinafter referred to as P40), the test substance, is a product that was developed for the purposes of improving its low absorbability in the fasting state, which is derived from high lipid-solubility, and its low processability. A study of single oral intake using rats and humans has shown that, compared to lipid-soluble CoQ 10 , uptake rate and volume of CoQ 10 are significantly higher for P40 when administered both postprandially and in the fasting state ( 11 ) . Considering this result, compared to soft-gel capsules, which are the common form for intake of lipid-soluble CoQ 10 , serum CoQ 10 concentration is to be expected higher with P40 even at the same dose; therefore, some safety concern was anticipated.
In the present study, male and female rats were treated orally by gavage with PureSorb-Q TM 40 once a day for 91 d, and its repeated dose toxicity was assessed as part of a series of non-clinical studies to evaluate the safety of P40.
The present study was conducted under Good Laboratory Practice (GLP).
MATERIALS AND METHODS
Test article and vehicle. PureSorb-Q TM 40 (Lot No. AQ1142V), the test substance, is a yellowish white to orange-colored powder and was supplied by Nisshin Pharma Inc. (Tokyo, Japan).
To make up dosing preparations, the test substance was suspended in a 0.5 w/v% solution of methylcellulose ("0.5 w/v% MC" hereafter). Dosing volumes were calculated at 10 mL/kg.
Test animals and housing conditions. Male and female Crl: CD (SD) rats aged 4 wk were received from Charles River Laboratories Japan, Inc. (Tokyo, Japan). After being quarantined for 5 d and acclimatized for 8 d, the animals were used for the study. The animals were housed individually in stainless steel suspended cages in an animal room at 21-23˚C and 39-63% RH on a 12-h light and dark cycle (lighting: 6:00 a.m.-6:00 p.m.) with fresh air change 12 times per hour. The animals were given free access to solid feed (CRF-1, Oriental Yeast Co., Ltd.) and tap water. The animals were used for the present study in accordance with the Regulations of the Committee for the Ethical Treatment of Animals issued by Nihon Bioresearch Inc.
Group composition and dose levels. The high and low dose levels were set at 2,000 and 1,000 mg/kg, respec- Observation and examination 1. Observation for general signs: The animals were observed for general signs twice a day, once before and once after administration.
2. Measurements of body weight and food consumption: The animals were weighed once a week. Food consumption was observed once a week.
3. Ophthalmological examination: The anterior of the eye was observed macroscopically and with a slitlamp before the start of administration and before completion of the dosing period. After dilation of the pupil with a mydriatic, the intermediate transillumination body was observed with the slit-lamp, and the fundi oculi were observed with an inverted microscope.
4. Urinalysis: Before completion of the dosing period, fresh urine was collected from the animals which were being fasted with water available, and then 24-h urine was collected from the animals which were being given feed and water. Using fresh urine and 24-h urine thus collected, urinalysis was performed as described below.
Fresh urine: Color was evaluated macroscopically. Regarding pH, protein, glucose, ketone body, bilirubin, occult blood, and urobilinogen, urine was examined with an automated urine analyzer (US-2100, Eiken Chemical Co., Ltd.). To observe urinary sediments, urine was centrifuged (at 493 ϫ g for 5 min). Then the supernatant fluid was removed, and urinary sediment stain (International Reagents Corporation) was dropped on the slight urine remaining at the bottom of the centrifuge tube. The materials in the tube were mixed well by shaking and then dropped on a glass slide to observe the urinary sediments microscopically. The incidence of epithelial cells, erythrocytes, and leukocytes in 100 fields and the presence or absence of casts and crystals in all fields were observed microscopically.
24-h urine: Urine specific gravity was measured with a specific gravity meter (Uripet-II D, Nikon Corporation). Na and K were determined by an ion selective electrode method, and Cl was determined by a coulometric titration method. These 3 urinary electrolytes were determined with an automated electrolyte analyzer (EA04, A&T Corporation). Daily total secretion (unit: mEq/d) of Na, K, and Cl was calculated from urine volume (unit: mL). Urine volume was obtained by converting the urine weight using urine specific gravity.
5. Hematological examination: Using blood collected the day after the last administration by cannulation via the abdominal aorta under anesthesia by intraperitoneal injection of pentobarbital sodium, hematological examination was performed as described below.
The blood, which had been collected into a tube coated inside with EDTA-2K, was examined for red blood cell count (RBC), white blood cell count (WBC), and platelet count (PLT) by a DC detection method, for hemoglobin concentration (HGB) by an SLS hemoglobin method, and for hematocrit level (HCT) by an RBC pulse height detection method. All of these parameters were determined with an automated hematology analyzer (Sysmex K-4500, Sysmex Corporation).
The mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC) were calculated from red blood cell count, hemoglobin concentration, or hematocrit level.
To examine prothrombin time (PT), activated partial thromboplastin time (APTT), and fibrinogen concentration (Fbg), plasma was obtained by centrifugation (at about 4˚C and 1,972 ϫ g for 15 min) of a mixture of the collected blood and 3.2 w/v% citric acid sodium at a volumetric ratio of 9 : 1. These parameters were determined by scattered light photometry with an automated coagulation analyzer (CA-530, Sysmex Corporation).
Reticulocyte count (RET) was determined as follows: Blood treated with EDTA-2K was stained supravitally by Brecher's method using new methylene blue and smeared on glass slides to prepare Giemsa stained specimens, and reticulocytes in 1,000 erythrocytes were counted out under a microscope.
Differential leucocytes (L: lymphocytes, N: neutrophils, E: eosinophils, B: basophils, and M: monocytes) were determined as follows: Blood treated with EDTA-2K was smeared on glass slides to prepare May-Giemsa stained specimens, and 100 leucocytes were counted out and classified under a microscope.
6. Blood chemical analysis: Blood was collected at the time of blood collection for the hematological examination, and serum was obtained from the blood by centrifugation (at about 4˚C and 1,972 ϫ g for 15 min). Using the serum, blood chemical analysis was performed as described below.
Using an automated chemistry analyzer (AU 400, Olympus Corporation), AST was determined by an MDH-UV method, ALT by an LDH-UV method, ALP by a p -nitro phenylphosphate substrate method, total cholesterol (T-Cho) by a COD·HDAOS method, triglycerides (TG) by a GPO·HDAOS method, total protein (TP) by Biuret method, urea nitrogen (UN) by a urease·GlDH method, creatinine (CRE) by a creatininase·F-DAOS method, total bilirubin (T-Bil) by a diazo method, glucose (Glu) by a hexokinase·G-6-PDH method, inorganic phosphorus (IP) by a PNP·XDH method, Ca by an o -CPC method, and Na, K, and Cl by an ion selective electrode method.
Proteinograms [albumin (alb), ␣ 1 -, ␣ 2 -, ␤ -, and ␥ -globulin (glb)] were examined by electrophoresis with an automated electrophoresis system (AES 310, Olympus Corporation). The albumin/globulin ratio (A/G) was calculated from the protein fraction values, and albumin concentration (Alb) was calculated from the protein fraction values and total protein value.
7. Necropsy and organ weight measurement: The animals from which blood had been collected for hematological examination and blood chemical analysis were euthanized by bleeding, and the organs and tissues were observed macroscopically. Subsequently, the following organs were removed and weighed: the brain, pituitary, salivary glands, thyroids, thymus, lungs, heart, liver, spleen, kidneys, adrenals, male reproductive organs (testes and prostate), and female reproductive organs (ovaries and uterus). The ratio of each organ weight to the body weight measured before necropsy, relative organ weight, was calculated.
8. Histopathological examination: According to a usual method, the following organs and tissues, which had been removed from the animals of the control and 2,000 mg/kg groups, were embedded in paraffin: the heart, aorta, lungs, trachea, liver, pancreas, tongue, salivary glands, digestive tract (esophagus, stomach, duodenum, jejunum, ileum, cecum, colon, and rectum), thymus, spleen, lymph nodes, kidneys, urinary bladder, male reproductive organs (testes, epididymides, seminal vesicles, and prostate), female reproductive organs (ovaries, uterus, and vagina), mammary glands, pituitary, adrenals, thyroids, parathyroids, brain, spinal cord, skin, eyeballs, Harderian glands, bones, and bone marrow. HE stained histological specimens of these organs and tissues were prepared and examined histopathologically.
Statistical methods. Group mean values and standard deviations were calculated for body weight, food consumption, urine volume, urine specific gravity, urinary electrolytes, hematological parameters, blood chemical parameters, and organ weights (relative weights included). Significance tests were performed by comparison between the control group and each of the groups treated with the test substance. Bartlett's test was performed for homogeneity of variance. When the variances were homogeneous, Dunnett's test was per- formed. When the variances were heterogeneous, a Dunnett-type test using a rank order was performed. Probabilities of less than 5% were considered statistically significant and are shown as p Ͻ 0.05 (less than 5%) or p Ͻ 0.01 (less than 1%).
RESULTS

General signs
No abnormal signs were noted in either sex in any group.
Body weight
Body weight changes in both sexes in the P40 groups were similar to those in the control group; no significant differences were seen on any day of measurement (Fig. 1) .
Food consumption
Changes in food consumption in both sexes in the P40 groups were similar to those in the control group; no significant differences were seen on any day of measurement (Fig. 2) .
Ophthalmological examination
No abnormalities were noted in the anterior of the eye, intermediate transillumination body, or fundi oculi in either sex in any group.
Urinalysis
No significant differences from the control group were seen in urine volume, urine specific gravity, or urinary electrolytes in the males of the P40 groups. Nor, were there any differences in color, pH, protein, glucose, ketone body, bilirubin, occult blood, or urobilinogen between the control group and either of the P40 groups. Regarding the females, K concentration was significantly lower in the 2,000 mg/kg group. However, there were no differences in color, pH, protein, glucose, ketone body, bilirubin, occult blood, urobilinogen, or urinary sediments between the control group and either of the P40 groups (Tables 1-1 
and 1-2).
Hematological examination No significant differences from the control group were seen in any hematological parameters in the males of the P40 groups. Significantly higher MCV was noted in the females of the 2,000 mg/kg group (Table  2) .
Blood chemical analysis
No significant differences from the control group were seen in any blood chemical parameters in either sex of animals of the P40 groups (Table 3) .
Organ weights
No significant differences from the control group were seen in the absolute or relative organ weights in animals of either sex of the P40 groups (Table 4) .
Necropsy findings
No abnormalities were noted in either sex in any group.
Histopathological examination
In the 2,000 mg/kg group, slight abnormalities were noted in the males as follows: cysts in the pituitary in 1 male, focal follicular cell hyperplasia in the thyroid (unilateral) in 1 male, ectopic tissues in the thyroid in 1 male, and lymphoid cellular infiltration in the prostates in 1 male. Slight abnormalities were also noted in the control group as follows: retinal dysplasia in the left eyeball in 1 male and mineralization in the subepithelial layer in the right eyeball in 2 males.
Regarding the females, slight abnormalities were noted as follows: mineralization in Peyer's patch in the jejunum in 1 female each of the control and 2,000 mg/ kg groups, microganuloma in the liver in 1 female of the 2,000 mg/kg group, and cysts in the pituiary in 1 female of the 2,000 mg/kg group.
DISCUSSION
Exogenous CoQ 10, such as dietary CoQ10, is absorbed by epithelial cells in the small intestine and transported via the lymphatic system to the liver, where most CoQ10 stays. CoQ10 absorption and metabolic pathway are believed to be broadly similar in rats and humans (12). 
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Exogenous and endogenous CoQ10 in the liver is bound to very low density lipoprotein (VLDL) and then secreted into blood (13) . The serum of healthy adults contains about 1 M of CoQ10, and most CoQ10 exists as reduced CoQ10 in the lipoprotein fraction (14) . Serum samples are often used to measure the absorption of exogenous CoQ10 or CoQ sufficiency in the body. However, marked differences have been seen in increased serum CoQ10 levels due to intake of exogenous CoQ10. This may be attributable to individual differences and dietary oil contents, and these factors have been shown to markedly affect serum CoQ10 levels (15). P40 is not affected by meals for the absorption of CoQ10. Our previous study of rats and humans showed that CoQ10 was well absorbed when P40 was administered even though in the fasting state (11) . The safety of CoQ10 has been reported (16). However, it was anticipated that the serum CoQ10 level might be higher with P40 than that of lipid-soluble CoQ10, for the same dose of CoQ10. Therefore, in this study, male and female rats were treated orally by gavage with P40 for 91 d, and its repeated dose toxicity was assessed.
No effects attributable to P40 were noted in general signs, body weight, food consumption, ophthalmological examination, blood chemical analysis, organ weights, or necropsy. In addition, although it is reported that exogenous CoQ 10 stayed in the liver, no significant change for AST or ALT was seen.
In the urinalysis, the K concentration was lower in the females at 2,000 mg/kg. However, there was no difference from the control group in daily total secretion of K, and no changes were noted in any other urinary electrolyte, and no abnormalities were noted at this dose level in the histopathological examination. Therefore, the lower K concentration is not considered to have been caused by P40.
In the hematological examination, higher MCV was noted in the females at 2,000 mg/kg. However, there were no other parameters whose values were abnormal at this dose level, and no abnormalities were noted at this dose level in the histopathological examination. Therefore, the higher MCV is not considered to have been caused by P40.
Histopathological abnormalities were noted at 2,000 mg/kg. However, some of the abnormalities were also noted in the control group, and all of the abnormalities, which were of small magnitude, were noted only in 1 or 2 animals. Therefore, the histopathological abnormalities are considered to be incidental changes commonly seen in toxicity studies.
In this study, the serum CoQ 10 level of rats was not analyzed. Therefore, it might be questionable that CoQ10 was actually absorbed in the body of rats. However, it was reported that CoQ10 in the P40 was well absorbed into the blood serum of rats (11) and the Cmax of CoQ10 plasma level in rats was 3.65 g/mL after 1,200 mg/kg day of normal CoQ10 bulk was administered for 13 wk (16) . Considering these data, it is anticipated that the serum CoQ10 level after 2,000 mg/kg of P40 (which is equivalent to 800 mg/kg of CoQ10) for 13 wk could be higher than that for the same amount of the normal CoQ10 bulk administration.
The major CoQ in rats is CoQ9 and that in rabbits is CoQ10. When CoQ10 was administered to these animals, very little difference in the metabolites of CoQ10 in urine was reported (17, 18) . Therefore, it is indicated that the result of the present study fully reflected the influence of the P40 orally administered to the rats.
As the conclusion, considering that no adverse effects of P40 were noted in general signs, body weight, food consumption, ophthalmological examination, blood chemical analysis, organ weights or necropsy, the no observed adverse effect level of P40 was estimated at 2,000 mg/kg in both sexes of rats under the conditions of the present study, and P40 was confirmed to be a food material which raises no safety concern.
